Regional overviews

celebrating 20 years USA & Canada

STATISTICS  
Number of products launched: 1 (2017: 3)#
IMS value of pipeline as at 30 June 2018 anticipated to be launched in:  
0 – 2 years USD449 million
3 – 5 years USD1 522 million
Number of product recalls: 0 (2017: 0)
Average staff turnover: 25,4% (2017: 24,1%)
Number of work-related fatalities: 0 (2017: Nil)
Number of permanent employees:  
Number of permanent employees:  

# The number of product launches has been restated as a result of the refinement of the product launch definition.

 

Aspen Pharmacare Canada was founded in 2014 to support our products distributed in this region. The development of our complex API capabilities into niche FDF offerings represents an opportunity for future product launches in the United States. Our satellite API facility in Sioux City supports the Oss site in supplying APIs worldwide.

KEY COUNTRIES

Canada, USA

Contribution to Group revenue

Revenue - R'million 2018 2017 (CER) % change
Regional Brands 113 442 (74)
Anaesthetics 304 251 21
Thrombosis 8 15 (47)
High Potency & Cytotoxics 136 293 (54)
Total 561 1 001 (44)
 
  • The Canadian pharmaceutical sector grew 7,8% and was valued at USD21 billion as at 31 December 2017.
  • The value of the US pharmaceutical sector grew 1,9% in 2017 while volumes declined 1,1%
Source: December 2018 IMS